HomeAI · summaries
Storia in 7 fonti
Landmark deals for cheaper ‘pandemic-ending’ HIV jab hailed as ‘huge’ step forward
Linda-Gail Bekker, who helped prove the drug Lenacapavir’s effectiveness, tells The Independent that $40 doses bring hope – but aid cuts still risk its rollout
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
askanews.it
Hiv/Aids, svolta storica: prevenzione a 34 euro l’anno dal 2027
Generico del lenacapavir in oltre 100 Paesi, accordo Unitaid-Gates
- ·
corriere.it
Lenacapavir a 40 dollari l’anno: la svolta storica per la prevenzione dell’Hiv nei Paesi a basso e medio reddito
Dal 2027 lenacapavir, il nuovo antiretrovirale a lunga durata d’azione, sarà disponibile in 120 Paesi a basso e medio reddito. Unitaid, CHAI, Wits RHI e Dr. Reddy’s siglano…
- ·
nytimes.com
Philanthropies Strike a Promising Deal to Turn Back H.I.V.
Low- and middle-income countries will be able to purchase an effective preventative at a reduced price. The arrangements may help stem the epidemic 40 years after it began.
- ·
theguardian.com
Cheap supplies of HIV-prevention jab for poorer countries hailed as ‘genuine chance to end’ global epidemic
Lenacapavir described as ‘next best thing’ to an HIV vaccine will cost $40 a year for each patient in 120 countries from 2027, funders say
- ·
bbc.com
Lenacapavir: Landmark deal paves way for cheaper HIV/ Aids protection jab
The drug - a twice-yearly injection – reduces the current HIV treatment cost in developing countries.
- ·
fortune.com
Gates Foundation partners with Indian drugmakers to speed rollout of $40 HIV shot | Fortune
A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more people.
- ·
independent.co.uk
Landmark deals for cheaper ‘pandemic-ending’ HIV jab hailed as ‘huge’ step forward
Linda-Gail Bekker, who helped prove the drug Lenacapavir’s effectiveness, tells The Independent that $40 doses bring hope – but aid cuts still risk its rollout